The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
Pharmacotherapy for neuropsychiatric disorders, such as anxiety and depression, has been characterized by significant inter-individual variability in drug response and the development of side effects.
Depression in Alzheimer’s Disease: A Delphi Consensus on Etiology, Risk Factors, and Clinical Management
Background: Alzheimer’s disease (AD) and other forms of dementia are among the most common causes of disability in the elderly. Dementia is often…
Focus on Depression in Parkinson’s Disease: A Delphi Consensus of Experts in Psychiatry, Neurology, and Geriatrics
Major and minor forms of depression are significant contributors to Parkinson’s disease morbidity and caregiver burden, affecting up…
